Increased oxidative stress during exercise predicts poor prognosis in patients with acute decompensated heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2021
Historique:
revised: 09 06 2021
received: 09 11 2020
accepted: 12 07 2021
pubmed: 31 7 2021
medline: 29 10 2021
entrez: 30 7 2021
Statut: ppublish

Résumé

Oxidative stress plays an important role in the development and progression of heart failure (HF). Although exercise and oxidative stress are closely related, the effect of acute exercise on reactive oxygen species production and the fluctuation on prognosis are unclear. We enrolled 94 patients who were hospitalized for worsening HF (mean age 68.0 ± 14.5 years old, 63.8% male). The changes in diacron-reactive oxygen metabolites (d-ROM) values, a marker of oxidative stress, before and after a cardiopulmonary exercise test were considered as Δd-ROM. The mean follow-up period was 24 ± 13 months, during which 15 patients had all-cause death or left ventricular assist system implantation. Kaplan-Meier analysis demonstrated that all-cause death or left ventricular assist system implantation was significantly higher in the Δd-ROM-positive group than in the Δd-ROM-negative group (log-rank P = 0.047). Elevated Δd-ROM levels were associated with increased mortality risk. Multivariate analysis adjusted for body mass index and peak oxygen uptake revealed that Δd-ROM was an independent prognostic factor of adverse events (Tertile 3 vs. 1; hazard ratio: 4.57; 95% confidence interval: 1.21-29.77; P = 0.022). Patients with HF who underwent a cardiopulmonary exercise test and had an increased oxidative stress marker level had a poor prognosis. The appropriate exercise intensity could be determined by evaluating the changes in oxidative stress status in response to acute exercise in patients with HF.

Identifiants

pubmed: 34327841
doi: 10.1002/ehf2.13538
pmc: PMC8497195
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3885-3893

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Circulation. 2007 Jun 19;115(24):3086-94
pubmed: 17548726
Anaesth Intensive Care. 2014 Jul;42(4):487-94
pubmed: 24967764
PLoS One. 2016 Feb 04;11(2):e0148209
pubmed: 26845691
Eur Heart J. 2014 Apr;35(16):1022-32
pubmed: 24618346
Circ Res. 1998 Mar 9;82(4):482-95
pubmed: 9506709
Mol Cell Biochem. 2003 Nov;253(1-2):307-12
pubmed: 14619981
Int Angiol. 1999 Jun;18(2):127-30
pubmed: 10424368
Circ Res. 1999 Aug 20;85(4):357-63
pubmed: 10455064
Circulation. 2014 Sep 16;130(12):966-75
pubmed: 25135276
Clin Chem Lab Med. 2002 Jul;40(7):673-6
pubmed: 12241012
Circulation. 2013 Aug 20;128(8):873-934
pubmed: 23877260
J Appl Physiol (1985). 1986 Jun;60(6):2020-7
pubmed: 3087938
Int J Cardiol. 2015 Jan 20;179:305-8
pubmed: 25464471
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
N Engl J Med. 1971 Dec 23;285(26):1441-6
pubmed: 5122894
J Nutr. 2001 Dec;131(12):3208-11
pubmed: 11739867
J Am Coll Cardiol. 1995 May;25(6):1239-49
pubmed: 7722116
Circ Res. 2013 Aug 30;113(6):646-59
pubmed: 23989710
Circulation. 2010 Jul 13;122(2):191-225
pubmed: 20585013
Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):309-42
pubmed: 18074940
N Engl J Med. 1985 Jan 17;312(3):159-63
pubmed: 2981404
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
FEMS Yeast Res. 2014 Feb;14(1):33-9
pubmed: 23965186
Circulation. 1991 Mar;83(3):778-86
pubmed: 1999029
JACC Heart Fail. 2013 Oct;1(5):427-32
pubmed: 24621975
ESC Heart Fail. 2021 Oct;8(5):3885-3893
pubmed: 34327841
J Am Coll Cardiol. 1998 May;31(6):1352-6
pubmed: 9581732
Aging (Albany NY). 2011 Sep;3(9):821-8
pubmed: 21931183
Eur Heart J. 1993 Nov;14(11):1493-8
pubmed: 8299631
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Circulation. 1998 Apr 28;97(16):1536-9
pubmed: 9593557

Auteurs

Atsushi Shibata (A)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yasuhiro Izumiya (Y)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yumi Yamaguchi (Y)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Ryoko Kitada (R)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shinichi Iwata (S)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shoichi Ehara (S)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yasukatsu Izumi (Y)

Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Akihisa Hanatani (A)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Minoru Yoshiyama (M)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH